Research Topics
| J HamannSummaryAffiliation: Klinikum rechts der Isar Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Do patients with schizophrenia wish to be involved in decisions about their medical treatment?Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Möhlstrasse 26, 81675 Munchen, Germany
Am J Psychiatry 162:2382-4. 2005..Little is known about the desire of patients with schizophrenia to be involved in medical decisions affecting their treatment...
How should patients behave to facilitate shared decision making - the doctors' viewJohannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Munich, Germany
Health Expect 15:360-6. 2012..Participants were requested to judge which patient behaviours they find helpful and which behaviours detrimental for SDM...
How do patients from eastern and western Germany compare with regard to their preferences for shared decision making?Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Germany
Eur J Public Health 22:469-73. 2012..This shift towards more patient engagement by health professionals and towards more desire by patients for participation may be partly based on socio-political factors...
"How to speak to your psychiatrist": shared decision-making training for inpatients with schizophreniaJohannes Hamann
Psychiatric Department, Technische Universitat Munchen, Munich, Germany
Psychiatr Serv 62:1218-21. 2011..This study evaluated a new intervention...
Psychiatric decision making in the adoption of a new antipsychotic in GermanyJohannes Hamann
Technische Universitat Munchen, Möhlstrasse 26, Muenchen, Germany 81675
Psychiatr Serv 57:700-3. 2006..Studies in somatic medicine have demonstrated delays in the implementation of new drugs, but data on psychiatric drugs are scarce. This study examined psychiatrists' adoption of a new antipsychotic...
Shared decision making for in-patients with schizophreniaJ Hamann
Psychiatric Department, Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munich, Germany
Acta Psychiatr Scand 114:265-73. 2006..In the present study, the feasibility and effects of SDM for in-patients with schizophrenia should be evaluated...
Shared decision making and long-term outcome in schizophrenia treatmentJohannes Hamann
Department of Psychiatry, Technische Universitat, Munich, Germany
J Clin Psychiatry 68:992-7. 2007..The aim of the present analysis was to study whether shared decision making (SDM) in antipsychotic drug choice would influence long-term outcome...
Participation preferences of patients with acute and chronic conditionsJohannes Hamann
Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU München, Munchen, Germany
Health Expect 10:358-63. 2007..There is little knowledge as to whether the chronicity of a disease affects patients' desire for participation...
[Complaint-management in psychiatry - a nationwide survey in Germany]Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
Psychiatr Prax 35:122-7. 2008..To describe and characterize the work of independent complaint offices for users of psychiatric services and of ombudsmen in psychiatric hospitals...
Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatmentJohannes Hamann
Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU München, Munchen, Germany
J Nerv Ment Dis 196:329-32. 2008..This is especially true of those being treated involuntarily...
Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topicsJohannes Hamann
Department of Psychiatry, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munchen, Germany
Psychiatr Serv 60:1107-12. 2009..This study explored psychiatrists' views of shared decision making in schizophrenia treatment...
How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Germany
Eur Neuropsychopharmacol 20:276-9. 2010..Other psychiatrist-related factors (e.g. age, gender, and work experience) did not influence attitudes toward depot...
Can psychiatrists and neurologists predict their patients' participation preferences?Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Munchen, Germany
J Nerv Ment Dis 198:309-11. 2010..More attention in the consultation should be paid to patients' preferences...
Patient participation in antipsychotic drug choice decisionsJohannes Hamann
Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Germany
Psychiatry Res 178:63-7. 2010..When working with patients exhibiting poor insight and negative drug attitudes, psychiatrists use authoritative decision-making styles despite the patient's desire to participate...
Why do some patients with schizophrenia want to be engaged in medical decision making and others do not?Johannes Hamann
Departments of Psychiatry and Psychotherapy, Technical University Munich, Munich, Germany
J Clin Psychiatry 72:1636-43. 2011..Our goal was to determine why some patients want to participate in medical decision making and others do not...
Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophreniaJohannes Hamann
Psychiatry Department, Technische Universitat Munchen, Germany
Psychiatr Serv 56:1448-50. 2005..Accordingly, patients' knowledge of the optimal duration of maintenance therapy was poor...
How do psychiatrists choose among different antipsychotics?Johannes Hamann
Department for Psychiatry and Psychotherapy, Technische Universitat, Möhlstrasse 26, 81675 Munich, Germany
Eur J Clin Pharmacol 61:851-4. 2005..We attempted to determine the decision rules psychiatrists use in the choice of antipsychotic drugs for inpatients with schizophrenia...
Postoperative acute confusional state in typical urologic population: incidence, risk factors, and strategies for preventionJohannes Hamann
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
Urology 65:449-53. 2005..Only a few studies, of highly selected urologic procedures, have been reported, and all showed an astonishingly low percentage of patients with this distressing condition...
Are the second-generation antipsychotics cost-effective? A critical review on the background of different health systemsJ Hamann
Klinik für Psychiatrie und Psychotherapie der Technischen Universität München
Pharmacopsychiatry 36:18-26. 2003..This has been criticized on the grounds that the higher acquisition costs of the new antipsychotics might be more than outweighed by savings in other fields, e. g., through a reduction in rehospitalizations or indirect costs...
[Effects of a shared decision making model in psychiatric and neurologic practice]J Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Germany
Nervenarzt 77:1071-6, 1078. 2006..This report provides a survey of this shared decision making model and a discussion of its implications in the fields of mental health and neurology...
[Shared decision making--from a model project towards implementation]Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
Z Arztl Fortbild Qualitatssich 98:115-9. 2004..Rather, there is an urgent need to encourage and empower patients to claim their rights to information and participation...
Shared decision making in psychiatryJ Hamann
Department of Psychiatry and Psychotherapy, Center for Disease Management, Technical University Munich, Germany
Acta Psychiatr Scand 107:403-9. 2003..In other medical fields, 'shared decision making' (a strategy for including patients in therapeutic decision processes) has been studied for several years now. This survey presents the potential of shared decision making for psychiatry...
Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription databaseJohannes Hamann
Center for Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
Int Clin Psychopharmacol 18:237-42. 2003..It is important to raise awareness among non-specialists about the indications, efficacy and side-effects of the antipsychotics because these physicians account for the majority of antipsychotic prescriptions...
Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatristsJ Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
Pharmacopsychiatry 36:309-12. 2003..They estimate that only about 10- 30 % of all patients with schizophrenia receive second-generation antipsychotics, a figure that lies significantly below the international average...
Patient participation in medical and social decisions in Alzheimer's diseaseJohannes Hamann
Department of Psychiatry, Technische Universitat Munchen, Munchen, Germany
J Am Geriatr Soc 59:2045-52. 2011....
How psychiatrists inform themselves and their patients about risks and benefits of antipsychotic treatmentR Mendel
Department of Psychiatry, Technische Universitat Munchen, Munich, Germany
Acta Psychiatr Scand 120:112-9. 2009..Our study aims to investigate whether psychiatrists actually do conduct such a balanced information search and presentation...
Medical decision making in antipsychotic drug choice for schizophreniaJohannes Hamann
Psychiatric Department, Technical University of Munich, Möhlstrasse 26, 81675 Munich, Germany
Am J Psychiatry 161:1301-4. 2004..The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed...
Clinical implications of Brief Psychiatric Rating Scale scoresStefan Leucht
Klinik fürr Psychiatrie und Psychotherapie derTechnischen Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munchen, Germany
Br J Psychiatry 187:366-71. 2005..Despite the widespread use of the Brief Psychiatric Rating Scale (BPRS), the clinical meaning of its total score and cut-off values used to define treatment response are unclear...
Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophreniaS Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie, der Technischen Universitaet Muenchen, am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Muenchen, Germany
Eur Psychiatry 26:297-301. 2011..Despite good clinical evidence, depot antipsychotics are only seldom prescribed to patients with first episode schizophrenia. The present study aims at investigating psychiatrists' reasons for this reservation...
Amisulpride is an "atypical" antipsychotic associated with low weight gainStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstrasse 22, 81675 Munich, Germany
Psychopharmacology (Berl) 173:112-5. 2004..While most "atypicals" have a high affinity for both dopamine and serotonin receptors, amisulpride has only dopamine receptor action...
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysisStefan Leucht
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Klinikum rechts der Isar, Munchen, Germany
Lancet 361:1581-9. 2003..We aimed to establish whether the new drugs induce fewer EPS than low-potency conventional antipsychotics...
Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysisStephan Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Muenchen, Germany
Prog Neuropsychopharmacol Biol Psychiatry 32:1987-93. 2008..In a first step to highlight this contradiction we aimed at identifying attributes of patients that indicate their qualification for depot treatment in the eyes of the psychiatrists...
What does the PANSS mean?Stefan Leucht
Klinik für Psychiatrie und Psychotherapie der TU München Klinikum rechts der Isar, Ismaningerstr 22, 81675 Munchen, Germany
Schizophr Res 79:231-8. 2005..g. at least 20% or 50% reduction of the baseline score) are as yet unclear. We therefore compared the PANSS with simultaneous ratings of Clinical Global Impressions (CGI)...
Linking the PANSS, BPRS, and CGI: clinical implicationsStefan Leucht
Klinik für Psychiatrie und Psychotherapie der TU München, Klinikum rechts der Isar, Munich, Munchen, Germany
Neuropsychopharmacology 31:2318-25. 2006..Clinicians seem to base CGI ratings on relative change rather than on absolute change of symptoms...
Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extendedStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
Biol Psychiatry 57:1543-9. 2005....
Attitudes of psychiatrists toward antipsychotic depot medicationStephan Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen, Universitaet Muenchen am Klinikum rechts der, Muenchen, Germany
J Clin Psychiatry 67:1948-53. 2006..Nevertheless, long-acting injectable formulations are seldom prescribed in the treatment of schizophrenia...
'What would you do if you were me, doctor?': randomised trial of psychiatrists' personal v. professional perspectives on treatment recommendationsRosmarie Mendel
Department of Psychiatry, Technische Universitat Munchen, Munchen, Germany
Br J Psychiatry 197:441-7. 2010....
Methodological issues in current antipsychotic drug trialsStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstr 22, 81675 Munchen, Germany
Schizophr Bull 34:275-85. 2008..The authors present practical examples to highlight the current problems and propose a concrete series of suggestions on how to further optimize antipsychotic drug trials in the future...
[Patient participation in german psychiatry - a critical review]Tatjana Reichhart
Centrum für Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
Psychiatr Prax 35:111-21. 2008..A comprehensive review of the present state and new approaches of patient participation in German psychiatry was conducted...
Language bias in neuroscience--is the Tower of Babel located in Germany?S Heres
Psychiatrische Klinik und Poliklinik, Technischen Universitaet Muenchen, Klinikum rechts der Isar, Ismaningerstrasse 22, Munich 81675, Germany
Eur Psychiatry 19:230-2. 2004..In the neurosciences a similar trend was seen but the findings were not statistically significant. The reason for this inconclusive finding might be the low number of RCTs published in German...
Medical decision making in the mental health fieldJohannes Hamann
Psychiatr Serv 56:221. 2005
Medication adherence studies in schizophreniaJohannes Hamann
Am J Psychiatry 161:582; author reply 582-3. 2004
Pretrial medication bias in randomized antipsychotic drug trialsStefan Leucht
Am J Psychiatry 164:1266; author reply 1266-7. 2007
